Abstract:The Rb/E2F network has a critical role in regulating cell cycle progression and cell fate decisions. It is dysfunctional in virtually all human cancers, because of genetic lesions that cause overexpression of activators, inactivation of repressors, or both. Paradoxically, the downstream target of this network, E2F1, is rarely strongly overexpressed in cancer. E2F1 can induce both proliferation and apoptosis but the factors governing these critical cell fate decisions remain unclear. Previous studies have focused on qualitative mechanisms such as differential cofactors, posttranslational modification or state of other signaling pathways as modifiers of the cell fate decisions downstream of E2F1 activation. In contrast, the importance of the expression levels of E2F1 itself in dictating the downstream phenotypes has not been rigorously studied, partly due to the limited resolution of traditional population-level measurements. Here, through single-cell quantitative analysis, we demonstrate that E2F1 expression levels have a critical role in determining the fate of individual cells. Low levels of exogenous E2F1 promote proliferation, moderate levels induce G1, G2 and mitotic cell cycle arrest, and very high levels promote apoptosis. These multiple anti-proliferative mechanisms result in a strong selection pressure leading to rapid elimination of E2F1-overexpressing cells from the population. RNA-sequencing and RT-PCR revealed that low levels of E2F1 are sufficient to induce numerous cell cycle-promoting genes, intermediate levels induce growth arrest genes (i.e., p18, p19 and p27), whereas higher levels are necessary to induce key apoptotic E2F1 targets APAF1, PUMA, HRK and BIM. Finally, treatment of a lung cancer cell line with a proteasome inhibitor, MLN2238, resulted in an E2F1-dependent mitotic arrest and apoptosis, confirming the role of endogenous E2F1 levels in these phenotypes. The strong anti-proliferative activity of moderately overexpressed E2F1 in multiple cancer types suggests that targeting E2F1 for upregulation may represent an attractive therapeutic strategy in cancer.

E2f1 Induces Tumor Cell Survival Via Nuclear Factor-Kappa B-Dependent Induction of Egr1 Transcription in Prostate Cancer Cells

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

Up-regulation of eEF1A2 promotes proliferation and inhibits apoptosis in prostate cancer.

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Expression of Nkx3.1 Enhances 17 Beta-Estradiol Anti-Tumor Action in PC3 Human Prostate Cancer Cells

E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1.

EB1 acts as an oncogene via activating beta-catenin/TCF pathway to promote cellular growth and inhibit apoptosis

A Molecular Link Between E2F-1 and the MAPK Cascade.

Expression level is a key determinant of E2F1-mediated cell fate

FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression

Transcription factor ETS1‑mediated ECT2 expression promotes the malignant behavior of prostate cancer cells

Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness

E2f1 Enhances 8-Chloro-adenosine-induced G2/M Arrest and Apoptosis in A549 and H1299 Lung Cancer Cells

Identification Of E1af As A Target Gene Of E2f1-Induced Apoptosis In Response To Dna Damage

Id-1 Expression Promotes Cell Survival Through Activation of NF-κB Signalling Pathway in Prostate Cancer Cells

Transcription Factor EGR-1 Suppresses the Growth and Transformation of Human HT-1080 Fibrosarcoma Cells by Induction of Transforming Growth Factor Beta 1.

Pac1 is A Direct Transcription Target of E2f-1 in Apoptotic Signaling